Scott Garland

2019 - Portola Pharmaceuticals

In 2019, Scott Garland earned a total compensation of $4.4M as President and Chief Executive Officer at Portola Pharmaceuticals, a 24% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$409,500
Option Awards$2,475,472
Salary$650,000
Stock Awards$815,710
Other$8,400
Total$4,359,082

Garland received $2.5M in option awards, accounting for 57% of the total pay in 2019.

Garland also received $409.5K in non-equity incentive plan, $650K in salary, $815.7K in stock awards and $8.4K in other compensation.

Rankings

In 2019, Scott Garland's compensation ranked 2,654th out of 13,971 executives tracked by ExecPay. In other words, Garland earned more than 81.0% of executives.

ClassificationRankingPercentile
All
2,654
out of 13,971
81st
Division
Manufacturing
958
out of 5,695
83rd
Major group
Chemicals And Allied Products
311
out of 2,194
86th
Industry group
Drugs
252
out of 1,880
87th
Industry
Pharmaceutical Preparations
185
out of 1,392
87th

Pay ratio

Scott Garland's Pay$4,359,082
Median Employee's Pay$291,408
Pay Ratio

15

to 1

In 2019, the annual total compensation of Scott Garland was $4,359,082.

The annual total compensation of the median employee at Portola Pharmaceuticals was $291,408.

The ratio of Scott Garland's pay to the pay of median employee was therefore 15 to one.

Source: SEC filing on April 20, 2020.

Garland's colleagues

We found four more compensation records of executives who worked with Scott Garland at Portola Pharmaceuticals in 2019.

2019

Sheldon Koenig

Portola Pharmaceuticals

Executive Vice President, Chief Commercial Officer

2019

Ernie Meyer

Portola Pharmaceuticals

Chief Human Resources Officer

2019

John Moriarty

Portola Pharmaceuticals

General Counsel

2019

Mardi Dier

Portola Pharmaceuticals

Executive Vice President, Chief Financial and Business Officer

News

In-depth

You may also like